Cover Image

Azelnidipine plus olmesartan versus amlodipine plus olmesartan on arterial stiffness and cardiac function in hypertensive patients: a randomized trial

Show other versions (1)

CorrigendumTakami T, Saito Y. Drug Design, Development and Therapy. 2013;7:175–183. On page 177, line 26, heading "Measurement of LVMI and LF diastolic function" should have been "Measurement of LVMI and LV diastolic function". Line 32, "Devereux et al18" should read &q...

Full description

Saved in:

Bibliographic Details
Main Authors:	Takami T (Author), Saito Y (Author)
Format:	Book
Published:	Dove Medical Press, 2013-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Azelnidipine plus olmesartan versus amlodipine plus olmesartan on arterial stiffness and cardiac function in hypertensive patients: a randomized trial
by: Takami T, et al.
Published: (2013)

Combination Therapy with Olmesartan and Amlodipine in the Treatment of Hypertension
by: Menco G. Niemeijer, et al.
Published: (2009)

Clinical Efficacy and Safety of Combination Therapy with Amlodipine and Olmesartan or an Olmesartan/Hydrochlorothiazide Compound for Hypertension: A Prospective, Open-Label, and Multicenter Clinical Trial in China
by: Pingjin Gao, et al.
Published: (2019)

Drug adherence to olmesartan/amlodipine fixed combination in an Italian clinical practice setting
by: Degli Esposti L, et al.
Published: (2014)

Enteropatía por olmesartán
Published: (2017)

Difference in the effects of switching from Candesartan to Olmesartan or Telmisartan to Olmesartan in hypertensive patients with type 2 diabetes: the COTO study
by: Daikuhara H, et al.
Published: (2014)

Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of amlodipine, olmesartan, and rosuvastatin in healthy adult subjects
by: Oh M, et al.
Published: (2019)

Enteropatía asociada a Olmesartan
by: Virginia González Hidalgo, et al.
Published: (2021)

Critical appraisal of amlodipine and olmesartan medoxomil fixed-dose combination in achieving blood pressure goals
by: Jan Basile
Published: (2010)

Integrated control of hypertension by olmesartan medoxomil and hydrochlorothiazide and rationale for combination
by: Punzi HA
Published: (2011)

Safety and tolerability of fixed antihypertensive combinations in blood pressure control: focus on olmesartan medoxomil and amlodipine combination
by: Ijlal Uddin, et al.
Published: (2010)

Impact of olmesartan on blood pressure, endothelial function, and cardiovascular outcomes
by: Eduardo Pimenta, et al.
Published: (2010)

Combined treatment with olmesartan medoxomil and amlodipine besylate attenuates atherosclerotic lesion progression in a model of advanced atherosclerosis
by: Sievers P, et al.
Published: (2015)

Bioequivalence evaluation of two amlodipine salts, besylate and orotate, each in a fixed-dose combination with olmesartan in healthy subjects
by: Lee SY, et al.
Published: (2015)

Development and characterization of nanosuspensions of olmesartan medoxomil for bioavailability enhancement
by: Hetal Paresh Thakkar, et al.
Published: (2011)

PHARMACOECONOMIC STUDY OF OLMESARTAN/LERCANIDIPINE AND OFENOPRIL/LERCANIDIPINE COMBINATIONS IN THE TREATMENT OF PATIENTS WITH ESSENTIAL HYPERTENSION
by: D. S. Kaskaeva, et al.
Published: (2017)

Comparative Effects of Azelnidipine and Amlodipine on Myocardial Function and Mortality After Ischemia/Reperfusion in Dogs
by: Seiichiro Kano, et al.
Published: (2011)

Effect of Probenecid on Pharmacokinetics and Tolerability of Olmesartan in Healthy Chinese Volunteers
by: Kun-Yan Li, PhD, et al.
Published: (2014)

Effects of telmisartan and olmesartan on insulin sensitivity and renal function in spontaneously hypertensive rats fed a high fat diet
by: Hayato Yanagihara, et al.
Published: (2016)

Olmesartan medoxomil-loaded mixed micelles: Preparation, characterization and in-vitro evaluation
by: Mohamed A. El-Gendy, et al.
Published: (2017)

Different chronotherapeutic effects of valsartan and olmesartan in non-dipper hypertensive patients during valsartan treatment at morning
by: Kentaro Ushijima, et al.
Published: (2015)

Efficacy and safety of fixed-dose combination therapy with olmesartan medoxomil and rosuvastatin in Korean patients with mild to moderate hypertension and dyslipidemia: an 8-week, multicenter, randomized, double-blind, factorial-design study (OLSTA-D RCT: OLmesartan rosuvaSTAtin from Daewoong)
by: Park JS, et al.
Published: (2016)

Efficacy and Safety of a Single-Pill Triple Combination of Olmesartan, Amlodipine, and Rosuvastatin in Hypertensive Patients with Low-to-Moderate Cardiovascular Risk: A Multicenter, Randomized, Open-Label, Active-Control, Phase IV Clinical Trial
by: Byung Jin Kim MD, PhD, et al.
Published: (2023)

Correction of Endothelial Dysfunction in Patients with Essential Hypertension when Using a Combination of Olmesartan/Lercanidipine and Zofenopril/Lercanidipine
by: O. V. Zimnitskaya, et al.
Published: (2016)

Hiperpigmentação da Face Induzida por Tratamento com Olmesartan Medoxomilo-Hidroclorotiazida
by: Miguel Costa-Silva, et al.
Published: (2018)

Design and Evaluation of An Extended-Release Olmesartan Tablet Using Chitosan/Cyclodextrin Composites
by: Makoto Anraku, et al.
Published: (2019)

Development of Transdermal Oleogel Containing Olmesartan Medoxomil: Statistical Optimization and Pharmacological Evaluation
by: Rania Moataz El-Dahmy, et al.
Published: (2023)

Sprue-Like Enteropathy and Liver Injury: A Rare Emerging Association with Olmesartan
by: Mihir Odak MD, et al.
Published: (2021)

Olmesartan Medoxomil, An Angiotensin II-Receptor Blocker, Ameliorates Renal Injury In db/db Mice
by: Zhu Y, et al.
Published: (2019)

Enhanced ex vivo intestinal absorption of olmesartan medoxomil nanosuspension: Preparation by combinative technology
by: Zenab Attari, et al.
Published: (2016)

Olmesartan Attenuates Single-Lung Ventilation Induced Lung Injury via Regulating Pulmonary Microbiota
by: Di Lu, et al.
Published: (2022)

Clinical use of azelnidipine in the treatment of hypertension in Chinese patients
by: Chen BL, et al.
Published: (2015)

In silico assessment of chronic toxicity of a combination drug namely 'Olmesartan medoxomil and Hydrochlorothiazide', marketed in Bangladesh
by: Matrika Saha Roy, et al.
Published: (2021)

Probable interacción entre Olmesartán y Rosuvastatina por inhibición de OATP1B1
by: Rodríguez Arcas MJ
Published: (2018)

Interaction and Compatibility Studies in the Development of Olmesartan Medoxomil and Hydrochlorothiazide Formulations under a Real Manufacturing Process
by: Mac Arturo Murillo-Fernández, et al.
Published: (2022)

The Preferential Inhibitory Effect of Olmesartan, a New Angiotensin II Type 1 Antagonist, on Sympathetic Nerve Terminals in Isolated Canine Splenic Artery
by: Shigetoshi Chiba, et al.
Published: (2003)

Integrated Quality by Design Approach for Developing Nanolipidic Drug Delivery Systems of Olmesartan Medoxomil with Enhanced Antihypertensive Action
by: Jagdish Kumar Arun, et al.
Published: (2020)

Azelnidipine Down-Regulates Renal Angiotensin-Converting Enzyme and Mineralocorticoid Receptor mRNA in Diabetic Hypertensive Rats
by: Tetsuya Nakamura, et al.
Published: (2006)

Doxycycline Plus Trimethoprim-Sulfamethoxazole versus Doxycycline plus Rifampicin in Treatment of Brucellosis: A Randomized Controlled Trial
by: Waleed A Hassan, et al.
Published: (2022)

Arterial stiffness and hypertension
by: Young S. Oh
Published: (2018)